Details for Patent: 3,666,858
✉ Email this page to a colleague
Summary for Patent: 3,666,858
| Title: | UTILIZATION OF GON-4-ENE THERAPY IN TREATMENT OF FEMALES AND IN GROWTH STIMULATION |
| Abstract: | Methods of using certain 13-ethyl-gon-4-enes are described, namely 13.beta.,17.alpha.-diethyl-17.beta.-hydroxygon-4-en-3-one, and the decanoate ester of 13.beta.-ethyl-17.beta.-hydroxygon-4-en-3-one for growth stimulation in mammals; and 13.beta.-ethyl-17.alpha.-ethynyl-17.beta.-hydroxygon-4-en-3-one, to treat dysfunctions of the female reproductive system in mammals, to control cyclic regularity, and to prevent conception in female mammals. |
| Inventor(s): | Hughes; Gordon Alan (Haverford, PA), Smith; Herchel (Wayne, PA) |
| Assignee: | SAID Smith, by said Hughes (N/A) |
| Application Number: | 04/649,800 |
|
Patent Claim Types: see list of patent claims | Composition; Use; |
Drugs Protected by US Patent 3,666,858
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 3,666,858
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Belgium | 716736 | ⤷ Sign Up | |||
| Cyprus | 658 | ⤷ Sign Up | |||
| Denmark | 130949 | ⤷ Sign Up | |||
| United Kingdom | 1204171 | ⤷ Sign Up | |||
| United Kingdom | 1204172 | ⤷ Sign Up | |||
| Ireland | 32912 | ⤷ Sign Up | |||
| Malaysia | 7300112 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
